Cargando…
Immunotherapy: a promising approach for glioma treatment
Gliomas are the most prevalent primary malignant brain tumors worldwide, with glioblastoma (GBM) being the most common and aggressive type. Despite two decades of relentless pursuit in exploring novel therapeutic approaches for GBM, there is limited progress in improving patients’ survival outcomes....
Autores principales: | Yasinjan, Feroza, Xing, Yang, Geng, Huayue, Guo, Rui, Yang, Lei, Liu, Ziling, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512462/ https://www.ncbi.nlm.nih.gov/pubmed/37744349 http://dx.doi.org/10.3389/fimmu.2023.1255611 |
Ejemplares similares
-
Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials
por: Xing, Yang, et al.
Publicado: (2023) -
Emerging trends and research foci of epithelial–mesenchymal transition in gliomas: A scientometric analysis and review
por: Xing, Yang, et al.
Publicado: (2022) -
Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023) -
Immunodiagnosis — the promise of personalized immunotherapy
por: Wang, Renjie, et al.
Publicado: (2023) -
Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022)